• Underlying EBITDA of $0.5m, up $0.3m vs prior year
• Revenue of $26.5m, up 34% year-over-year and 27% on constant currency basis
• Annualised Recurring Revenue of $30.0m, up 20% year-over-year and 24% on constant currency basis

IMEXHS Ltd, a provider of innovative, cloud-based, AI medical imaging software solutions and radiology services, has reported its unaudited FY24 results. The company achieved revenue of $26.5m, up 34% year-over-year and 27% on a constant currency basis. Annualised Recurring Revenue (ARR) grew 20% year-over-year to $30.0m, and was up 24% on a constant currency basis. The company reported underlying EBITDA of $0.5m, up $0.3m versus the prior year. Key operational highlights included contract renewals and new business wins in both the software and radiology services divisions, as well as progress on the company's 'New Value Proposition' software development program. The balance sheet remained strong, with closing cash of $2.1m and net assets of $14.5m. The company is focused on generating positive earnings and cash flow, with a geographic focus on Latin America, and expects to provide specific FY25 guidance at the half-year.

The company expects strong revenue growth and to be EBITDA and cash positive for 2025. More of the growth in Revenue, Earnings and Cash will occur in H2 2025.

The company expects continuing momentum from recent contract wins in H1 2025, with an acceleration of software sales as the 'New Value Proposition' software is rolled out to new and existing customers in H2 2025. The Radiology Profit Improvement Program is also expected to improve radiology services performance through the year.